Pascale De Becker: Difference between revisions
From MEpedia, a crowd-sourced encyclopedia of ME and CFS science and history
Notjusttired (talk | contribs) m (Text replacement - "[[[[" to "[[") |
Notjusttired (talk | contribs) m (Text replacement - " \|" to " |") |
||
| Line 51: | Line 51: | ||
<ref name="Activity Limitations, 2002"> | <ref name="Activity Limitations, 2002"> | ||
{{Cite journal | {{Cite journal | ||
| last1 = Nijs | first1 = Jo | | last1 = Nijs | first1 = Jo | authorlink1 = Jo Nijs | ||
| last2 = Vaes | first2 = Peter | authorlink2 = | | last2 = Vaes | first2 = Peter | authorlink2 = | ||
| last3 = Van Hoof | first3 = Elke | authorlink3 = Elke Van Hoof | | last3 = Van Hoof | first3 = Elke | authorlink3 = Elke Van Hoof | ||
| Line 67: | Line 67: | ||
<ref name="bronchial hyperresponsiveness, 2003"> | <ref name="bronchial hyperresponsiveness, 2003"> | ||
{{Citation | {{Citation | ||
| last1 = Nijs | first1 = Jo | | last1 = Nijs | first1 = Jo | authorlink1 = Jo Nijs | ||
| last2 = De Becker | first2 = Pascale | authorlink2 = Pascale De Becker | | last2 = De Becker | first2 = Pascale | authorlink2 = Pascale De Becker | ||
| last3 = De Meirleir | first3 = Kenny L. | authorlink3 = Kenny De Meirleir | | last3 = De Meirleir | first3 = Kenny L. | authorlink3 = Kenny De Meirleir | ||
| Line 82: | Line 82: | ||
</ref> | </ref> | ||
<ref name="DeBecker2000">{{Citation | <ref name="DeBecker2000">{{Citation | ||
| last1 = De Becker | first1 = P | | last1 = De Becker | first1 = P | authorlink1 = Pascale De Becker | ||
| last2 = Roeykens | first2 = J | | last2 = Roeykens | first2 = J | authorlink2 = Johan Roeykens | ||
| last3 = Reynders | first3 = M | | last3 = Reynders | first3 = M | authorlink3 = Masha Reynders | ||
| last4 = McGregor | first4 = N | | last4 = McGregor | first4 = N | authorlink4 = Neil McGregor | ||
| last5 = De Meirleir | first5 = K | | last5 = De Meirleir | first5 = K | authorlink5 = Kenny de Meirleir | ||
| title = Exercise capacity in chronic fatigue syndrome | | title = Exercise capacity in chronic fatigue syndrome | ||
| Line 97: | Line 97: | ||
<ref name="Hypothetical Channelopathy, 2003"> | <ref name="Hypothetical Channelopathy, 2003"> | ||
{{Citation | {{Citation | ||
| last1 = Nijs | first1 = Jo | | last1 = Nijs | first1 = Jo | authorlink1 = Jo Nijs | ||
| last2 = De Becker | first2 = Pascale | authorlink2 = Pascale De Becker | | last2 = De Becker | first2 = Pascale | authorlink2 = Pascale De Becker | ||
| last3 = Demanet | first3 = Christian | authorlink3 = | | last3 = Demanet | first3 = Christian | authorlink3 = | ||
| Line 113: | Line 113: | ||
<ref name="Nijs, 2002"> | <ref name="Nijs, 2002"> | ||
{{Citation | {{Citation | ||
| last1 = Nijs | first1 = Jo | | last1 = Nijs | first1 = Jo | authorlink1 = Jo Nijs | ||
| last5 = Nicolson | first5 = Garth L. | authorlink5 = Garth Nicolson | | last5 = Nicolson | first5 = Garth L. | authorlink5 = Garth Nicolson | ||
| last4 = De Becker | first4 = Pascale | authorlink4 = Pascale De Becker | | last4 = De Becker | first4 = Pascale | authorlink4 = Pascale De Becker | ||
| Line 128: | Line 128: | ||
<ref name="Nijs, et al, 2003"> | <ref name="Nijs, et al, 2003"> | ||
{{Citation | {{Citation | ||
| last1 = Nijs | first1 = Jo | | last1 = Nijs | first1 = Jo | authorlink1 = Jo Nijs | ||
| last2 = Coomans | first2 = Danny | | last2 = Coomans | first2 = Danny | authorlink2 = | ||
| last3 = Nicolson | first3 = Garth L. | authorlink3 = Garth Nicolson | | last3 = Nicolson | first3 = Garth L. | authorlink3 = Garth Nicolson | ||
| last4 = De Becker | first4 = Pascale | authorlink4 = Pascale De Becker | | last4 = De Becker | first4 = Pascale | authorlink4 = Pascale De Becker | ||
| Line 143: | Line 143: | ||
<ref name="Nijs, De Meirleir, et al, 2003"> | <ref name="Nijs, De Meirleir, et al, 2003"> | ||
{{Citation | {{Citation | ||
| last1 = Nijs | first1 = Jo | | last1 = Nijs | first1 = Jo | authorlink1 = Jo Nijs | ||
| last2 = De Meirleir | first2 = Kenny L. | authorlink2 = Kenny De Meirleir | | last2 = De Meirleir | first2 = Kenny L. | authorlink2 = Kenny De Meirleir | ||
| last3 = Coomans | first3 = Danny | | last3 = Coomans | first3 = Danny | authorlink3 = | ||
| last4 = De Becker | first4 = Pascale | authorlink4 = Pascale De Becker | | last4 = De Becker | first4 = Pascale | authorlink4 = Pascale De Becker | ||
| last5 = Nicolson | first5 = Garth L. | authorlink5 = Garth Nicolson | | last5 = Nicolson | first5 = Garth L. | authorlink5 = Garth Nicolson | ||
| Line 172: | Line 172: | ||
| last1 = Van Hoof | first1 = E | authorlink1 = Elke Van Hoof | | last1 = Van Hoof | first1 = E | authorlink1 = Elke Van Hoof | ||
| last2 = De Becker | first2 = P | authorlink2 = Pascale De Becker | | last2 = De Becker | first2 = P | authorlink2 = Pascale De Becker | ||
| last3 = Lapp | | last3 = Lapp | first3 = C | authorlink3 = Charles Lapp | ||
| last4 = Cluydts | | last4 = Cluydts | first4 = R | authorlink4 = | ||
| last5 = De Meirleir | first5 = K | authorlink5 = Kenny de Meirleir | | last5 = De Meirleir | first5 = K | authorlink5 = Kenny de Meirleir | ||
| title = Defining the Occurrence and Influence of Alpha-Delta Sleep in Chronic Fatigue Syndrome | | title = Defining the Occurrence and Influence of Alpha-Delta Sleep in Chronic Fatigue Syndrome | ||
Revision as of 05:01, May 11, 2022
Pascale De Becker, PhD, researched ME/CFS at Department of Human Physiology, Faculty of Physical Education and Physiotherapy, Vrije Universiteit Brussel, Brussels, Belgium.
Awards[edit | edit source]
- 1998, Junior Investigator Award awarded by IACFSME in order to encourage young CFS/FM researchers in recognition of their work[1]
Books[edit | edit source]
- 2002, Chapter 8 - "CFS etiology, the immune system, and infection" in CFS Etiology, the Immune System, and Infection: A Biological Approach, Chapter: 8, Publisher: CRC Press, New York, Editors: K. De Meirleir, P. Englebienne, pp.201-228[2]
Notable studies[edit | edit source]
- 2000, Exercise capacity in chronic fatigue syndrome[3] (Full Text)
- 2001, A definition-based analysis of symptoms in a large cohort of patients with chronic fatigue syndrome[4] (Full Text)
- 2002, High prevalence of Mycoplasma infections among European chronic fatigue syndrome patients. Examination of four Mycoplasma species in blood of chronic fatigue syndrome patients[5] (Full Text)
- 2002, Activity Limitations and Participation Restrictions in Patients with Chronic Fatigue Syndrome—Construction of a Disease Specific Questionnaire[6] (Abstract)
- 2002, Possible Triggers and Mode of Onset of Chronic Fatigue Syndrome[7] (Abstract)
- 2003, Associations between bronchial hyperresponsiveness and immune cell parameters in patients with chronic fatigue syndrome[8] (Abstract)
- 2003, Monitoring a Hypothetical Channelopathy in Chronic Fatigue Syndrome: Preliminary Observations[9] (Abstract)
- 2003, Hyperbaric Therapy in Chronic Fatigue Syndrome[10] (Abstract)
- 2003, Deregulation of the 2,5A Synthetase RNase L Antiviral Pathway by Mycoplasma spp. in Subsets of Chronic Fatigue Syndrome[11] (Full Text)
- 2003, Immunophenotyping Predictive of Mycoplasma Infection in Patients with Chronic Fatigue Syndrome?[12] Abstract)
- 2003, High Prevalence of Mycoplasma Infections in Symptomatic (Chronic Fatigue Syndrome) Family Members of Mycoplasma-Positive Gulf War Illness Patients[13] (Full Text)
- 2003, Nutritional Supplement (NT Factor™) Restores Mitochondrial Function and Reduces Moderately Severe Fatigue in Aged Subjects[14]
- 2006, Pediatric Chronic Fatigue Syndrome and Munchausen-By-Proxy: A Case Study[15] (Abstract)
- 2007, Defining the Occurrence and Influence of Alpha-Delta Sleep in Chronic Fatigue Syndrome[16] (Abstract)
Talks and interviews[edit | edit source]
Online presence[edit | edit source]
- PubMed
- Website
- YouTube
Learn more[edit | edit source]
See also[edit | edit source]
- Myalgic encephalomyelitis
- Chronic fatigue syndrome
- Definitions of myalgic encephalomyelitis and chronic fatigue syndrome
- Severe and very severe ME
References[edit | edit source]
- ↑ "IACFS/ME Awardees". IACFS/ME. Retrieved April 23, 2020.
- ↑ De Meirleir, K & De Becker, P & Nijs, Jo & L. Peterson, D & Nicolson, Garth & Patarca-Montero, R & Englebienne, P. (2002). CFS etiology, the immune system, and infection. 201-228.
- ↑ De Becker, P; Roeykens, J; Reynders, M; McGregor, N; De Meirleir, K (November 27, 2000), "Exercise capacity in chronic fatigue syndrome", Archives of Internal Medicine, 160 (21): 3270–3277, doi:10.1001/archinte.160.21.3270, ISSN 0003-9926, PMID 11088089
- ↑ De Becker, P; McGregor, N; De Meirleir, K (September 2001). "A definition-based analysis of symptoms in a large cohort of patients with chronic fatigue syndrome". Journal of Internal Medicine. 250 (3): 234-240. PMID 11555128.
- ↑ Nijs, Jo; De Meirleir, Kenny L.; Coomans, Danny; De Becker, Pascale; Nicolson, Garth L. (2002), "High prevalence of Mycoplasma infections among European chronic fatigue syndrome patients. Examination of four Mycoplasma species in blood of chronic fatigue syndrome patients", FEMS Immunology and Medical Microbiology, 34 (3): 209-14, doi:10.1111/j.1574-695X.2002.tb00626.x, PMID 12423773
- ↑ Nijs, Jo; Vaes, Peter; Van Hoof, Elke; De Becker, Pascale; McGregor, Neil; De Meirleir, Kenny L. (2002). "Activity Limitations and Participation Restrictions in Patients with Chronic Fatigue Syndrome—Construction of a Disease Specific Questionnaire". Journal of Chronic Fatigue Syndrome. 10 (2): 3-23. doi:10.1300/J092v10n03_02.
- ↑ P. De Becker, N. McGregor & K. De Meirleir. (2002). Possible Triggers and Mode of Onset of Chronic Fatigue Syndrome. Journal of Chronic Fatigue Syndrome, Vol. 10, Iss. 2, pp. 3-18. http://dx.doi.org/10.1300/J092v10n02_02
- ↑ Nijs, Jo; De Becker, Pascale; De Meirleir, Kenny L.; Demanet, Christian; Vincken, Walter; Schuermans, Daniel; McGregor, Neil (2003), "Associations between bronchial hyperresponsiveness and immune cell parameters in patients with chronic fatigue syndrome", Chest, 123 (4): 998-1007, PMID 12684286
- ↑ Nijs, Jo; De Becker, Pascale; Demanet, Christian; McGregor, Neil; Englebienne, Patrick; Verhas, Michel; De Meirleir, Kenny L. (2003), "Monitoring a Hypothetical Channelopathy in Chronic Fatigue Syndrome: Preliminary Observations", Journal of Chronic Fatigue Syndrome, 11 (1): 117-133, doi:10.1300/J092v11n01_03
- ↑ Elke Van Hoof, Danny Coomans, Pascale De Becker, Romain Meeusen, Raymond Cluydts & Kenny De Meirleir. (2003). Hyperbaric Therapy in Chronic Fatigue Syndrome Journal of Chronic Fatigue Syndrome, Vol. 11, Iss. 3, pp. 37-49. DOI:10.1300/J092v11n03_04
- ↑ Nijs, Jo; De Meirleir, Kenny L.; Coomans, Danny; De Becker, Pascale; Nicolson, Garth L. (2003), "Deregulation of the 2,5A Synthetase RNase L Antiviral Pathway by Mycoplasma spp. in Subsets of Chronic Fatigue Syndrome" (PDF), Journal of Chronic Fatigue Syndrome, 11 (2): 37-50, doi:10.1300/J092v11n02_04
- ↑ Nijs, Jo; Coomans, Danny; Nicolson, Garth L.; De Becker, Pascale; Christian, Demanet; De Meirleir, Kenny L. (2003), "Immunophenotyping Predictive of Mycoplasma Infection in Patients with Chronic Fatigue Syndrome?", Journal of Chronic Fatigue Syndrome, 11 (2): 51-69, doi:10.1300/J092v11n02_05
- ↑ Nijs J, Nicolson GL, De Becker P, Coomans D, De Meirleir K. (2002). High prevalence of Mycoplasma infections among European chronic fatigue syndrome patients. Examination of four Mycoplasma species in blood of chronic fatigue syndrome patients. Pathogens and Disease, Vol 34, Iss 3, pp 209-214
- ↑ Elke Van Hoof, Danny Coomans, Pascale De Becker, Romain Meeusen, Raymond Cluydts & Kenny De Meirleir (2003). Nutritional Supplement (NT Factor™) Restores Mitochondrial Function and Reduces Moderately Severe Fatigue in Aged Subjects. Journal of Chronic Fatigue Syndrome, Vol. 11, Iss. 3, pp. 37-49. http://dx.doi.org/10.1300/J092v11n03_04
- ↑ Van Hoof, E; De Becker, P; De Meirleir, K (2006), "Pediatric Chronic Fatigue Syndrome and Munchausen-By-Proxy: A Case Study", Journal of Chronic Fatigue Syndrome, 13 (2–3): 45-53, doi:10.1300/J092v13n02_02
- ↑ Van Hoof, E; De Becker, P; Lapp, C; Cluydts, R; De Meirleir, K (2007), "Defining the Occurrence and Influence of Alpha-Delta Sleep in Chronic Fatigue Syndrome", The American Journal of the Medical Sciences, 333 (2): 78-84, PMID 17301585
